Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, pleas
Yes — Apellis Pharmaceuticals has 15 open jobs on JobsRadar right now, across 3 departments and 5 locations. 2 of them were opened in the last 30 days. 11 of them disclose pay, at a median of $169,000 a year. The board was last refreshed on October 28, 2026 at 08:07 UTC.